Product Details
Efficient and Accurate CKMB Test for Rapid Cardiac Marker Detection
CKMB-W21
Product Description:
Cardiac markers are a crucial component in the diagnosis and
management of acute coronary syndromes. CK-MB is one such marker
that is used to detect damage to heart muscle cells. The CKMB-W21
test is a cassette format assay that can accurately measure CK-MB
levels in serum, plasma, or whole blood specimens.
With a sensitivity of 5ng/ml, this CKMB test is highly accurate and
reliable in detecting early stages of myocardial infarction. The
cassette format of the test allows for quick and easy
interpretation of results, making it a convenient option for use in
emergency situations. The test is easy to use, requiring only a few
simple steps, and can be performed by healthcare professionals in a
variety of settings.
The CKMB-W21 test is also cost-effective, making it a practical
option for healthcare providers seeking to improve patient care
while maintaining fiscal responsibility. With a standard pack of 25
tests, the test is ideal for small clinics, emergency departments,
and other medical facilities.
In summary, the CKMB-W21 test is an efficient and accurate cardiac
marker test that provides rapid detection of myocardial infarction
in serum, plasma, or whole blood specimens. With a cassette format,
high sensitivity, and cost-effective pricing, this test is an
excellent choice for healthcare providers looking to improve
patient outcomes.
Company Profile
Huizhu LIna Medical is a high-tech biopharmaceutical company specializing in
the research, development, production, and sales of IVD reagents
and related instruments.
Most of our R & D team members have more than 8 years of experience
in POCT product development. They have already successfully
optimized our products and are working on a new product development
projects efficiently.

At present, we mainly focus on two areas of research: chronic
disease health management and instant diagnostic reagents, they are
extensively used in the fields of self-test, clinical biochemistry,
and immunology.The main products are as follows:
• Blood Glucose Monitors
• Blood Glucose Uric Acid Meter
• Hemoglobin Meter
• Blood Lipids Analysis Meter(Total Cholesterol, High-Density
Lipoprotein Cholesterol, Triglycerides)
• Renal function Analysis Meter(Creatinine, Uric Acid, Urea)
• Dry Biochemical Analysis Meter(TC,HDL,TG,CR,UA,UR)
• Detection of infectious diseases (including COVID-19 detection
products)
• Drugs of abuse
• Fertility
• Tumor marker
• Cardiac marker detection
As a professional manufacturer and service provider in the IVD
industry, “Huizhu”plays a major role in the fields of biochemistry
and immunology for both home and clinical use. “Huizhu” has passed the EN ISO 13485:2016 quality management system
certification. Relevant IVD products have obtained the EU CE
certification.
“Huizhu” is granted "white list" membership by the Chinese Ministry of
Commerce for the anti-epidemic products exportation. At present, “Huizhu” COVID-19 Antigen Rapid Test Device has been registered in many
countries including Germany, France, Italy, Switzerland, Slovakia,
Czech, Indonesia, Thailand, Malaysia etc., and passed the clinical
validation in a national lab in Germany, Switzerland, Malaysia,
etc. The products show good performance in sensitivity and
specificity compared with industry-leading products and have been
exported to more than 30 countries and regions.